Trinity Biotech plc (NASDAQ:TRIB – Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 1,900 shares, an increase of 58.3% from the March 31st total of 1,200 shares. Based on an average daily volume of 94,300 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are short sold.
Trinity Biotech Stock Performance
Shares of Trinity Biotech stock opened at $1.83 on Monday. Trinity Biotech has a 12 month low of $1.79 and a 12 month high of $5.50. The stock’s fifty day moving average price is $2.01 and its 200-day moving average price is $2.23.
Trinity Biotech (NASDAQ:TRIB – Get Free Report) last announced its quarterly earnings results on Thursday, April 4th. The company reported ($0.68) EPS for the quarter. The firm had revenue of $13.43 million during the quarter. On average, equities research analysts forecast that Trinity Biotech will post -1.5 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on TRIB
About Trinity Biotech
Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
See Also
- Five stocks we like better than Trinity Biotech
- How to Use Stock Screeners to Find Stocks
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- ETF Screener: Uses and Step-by-Step Guide
- MarketBeat Week in Review – 4/22 – 4/26
- Compound Interest and Why It Matters When Investing
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for Trinity Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trinity Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
